ArticleFrontiers in pediatrics2026
Management of patent ductus arteriosus in preterm neonates ≤32 weeks: a national survey of physician practices in Indian NICUs.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patent Ductus Arteriosus is very common in preterm neonates ≤ 32 weeks gestation, and practice variations, particularly in high-income countries have been reported, with minimal reports from LMIC countries like India. We aim to determine the current physician practices prevalent in the management of preterm PDA in neonates ≤ 32 weeks, in India. Methods: This 25-question survey was sent to physicians working in in Level III, II, and I NICUs in India. Results: 238 neonatal physicians responded to the survey (response rate 57.8%), revealing that 81.5% worked in Level III units. 60% respondents had access to an echo machine in the NICU, while 13.9% did not have an echo machine in their units. 39.9% physicians reported being formally trained in neonatal echocardiography/proficient through experience, whereas 20.2% did not perform neonatal echocardiography. 40.7% respondents reported that echocardiography was performed by adult/ paediatric cardiologists. 62.2% preferred an 'early-symptomatic treatment' strategy, while 29.4% favoured an 'early-targeted treatment' approach for ELBW neonates. Paracetamol was the first-line drug choice for 80% respondents (intravenous preferred over oral), followed by oral Ibuprofen (16.4%). 57.6% clinicians repeated the same drug for the second course when needed, and a similar number performed an echo-reassessment after completion of the full treatment course. 68.9% attempted medical closure up to two times, whereas access to surgical closure was limited for 70.5% of physicians. Conclusions: Access to echocardiography machines has improved in the last few years in India, though, even now, less than half of our neonatal physicians are appropriately trained in performing neonatal echocardiography. Physicians prefer an 'early symptomatic treatment' strategy and use Paracetamol as the first-line management, which differs from international practices. Access to surgical options in Indian NICUs is limited. Though management approaches are similar among physicians, critical areas such as echo availability, access to advanced echo training, and surgical (device) closure of PDA still need improvement to ensure equitable and optimal care for neonates with HsPDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.